When Will Mounjaro Prices Go Up — and What It Means for You

What happened to Mounjaro prices in September 2025

The September 2025 price change was significant and broadly reported. Eli Lilly adjusted UK list prices across the dose range, with the sharpest increase at the top: the 15mg pen moved from roughly £122 to roughly £330 per four-week supply. Lower doses saw smaller but still notable increases. Private providers who had been absorbing or passing on the original pricing had to respond, and typical private-market prices since then range from around £149 per month at the starter end to around £375 at the highest doses, depending on the provider and what is included in that figure.

One misconception worth letting go gently: many people assume the September increase was a temporary or introductory correction that will reverse. There is no published signal from Eli Lilly suggesting that. Pharmaceutical list prices in the UK tend to move in one direction over time, particularly for medicines still under patent and with growing clinical evidence behind them. Our full Mounjaro pricing page sets out the current context in more detail.

What remains genuinely uncertain is whether a further increase is coming, and on what timeline. If you are trying to understand when Mounjaro prices go up and what tends to trigger those changes, Lilly has not announced one and watching for official statements is the only reliable way to track it; speculation from forums or social media is not a useful guide for a decision this financial.

What published prices often leave out

When you see a headline monthly figure for Mounjaro (whether £149 or £299 or anything in between) the relevant question is what that figure actually covers. A prescription-only medicine legally requires a prescriber to assess your suitability. That consultation has a cost, whether it appears on the invoice or not.

Common items that headline prices exclude: an initial consultation fee charged separately, a prescription fee on top, delivery costs (sometimes per-order, sometimes gated behind a minimum spend), dose-titration reviews when you move up through the schedule, and access to clinical support if side effects arise between doses. A lower headline figure with four add-ons can easily land higher than a single all-in price.

For anyone currently comparing options, our guide to online clinic pricing walks through the line items worth checking before you commit to any provider. The arithmetic is often more surprising than the headline.

Where nume sits on price, and why

We are not the cheapest option available. That is a deliberate choice, not an oversight. One price covers everything: the clinical consultation, the prescription, the medicine itself, next-working-day tracked DPD delivery, and seven-day aftercare. No add-ons appear later. Every repeat order is clinically re-reviewed by a GPhC-registered prescriber, the same rigour as the first. You can read more about how we work if you want the full picture before starting.

We do not run discount codes, promotional pricing or time-limited offers. Mounjaro is a prescription medicine, not a consumer product with a sale cycle. If you see a discount code attached to a GLP-1 medicine from an unverified seller, that is a red flag worth taking seriously, the MHRA has warned publicly about counterfeit weight-loss pens sold online, some of which have caused serious harm. Verifying any online pharmacy on the GPhC register takes about thirty seconds and is the simplest check you can run.

Our prescribers are named, our pharmacy is GPhC-registered (premises number 9012878), and every consultation is reviewed the same day it is submitted. Our clinical lead's profile is publicly available if you want to see who is making prescribing decisions.

Price is not the right measure for a prescription medicine

The question of when Mounjaro prices will rise again is genuinely worth asking. But the more useful framing, for a medicine that requires a prescriber, is whether the service around the prescription is one you can trust. A small saving per month does not offset a counterfeit pen, an unchecked contraindication, or a dose increase approved without any clinical evidence. Those risks are real. The MHRA's enforcement operations through 2025 seized around 20 million doses of illegally traded weight-loss medicines worth roughly £45 million, that is the scale of the counterfeit market you are navigating if you prioritise price above everything else.

If timing matters to you, the honest answer is: prices rose in September 2025 and the situation is worth monitoring. There is no confirmed further increase, but there is also no reason to expect the pre-2025 price floor to return. You can explore whether Mounjaro will go up in price and what factors are likely to influence that, look at when exactly the Mounjaro price tends to go up and how much notice is typically given, or explore the factors likely to influence future pricing or look at whether any downward movement is realistic before making a decision.

If you are ready to find out whether Mounjaro is clinically suitable for you, the consultation is free, and a real prescriber reviews it the same day. Check your eligibility and take it from there.